Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion type Assertion NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_head.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion description "[As previous studies demonstrated both an increase in PGE2 synthesis and an up-regulation of COX-2 and iNOS mRNA by ischemia-reperfusion injury in the model (Braun and Kietzmann, 2004), inhibitory effects of the glucocorticoid dexamethasone, the NSAID flunixin and the selective COX-2 inhibitor DFU (5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl)-phenyl-2-(5H)-furanone) were studied.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_provenance.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion evidence source_evidence_literature NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_provenance.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion SIO_000772 15057408 NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_provenance.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion wasDerivedFrom befree-2016 NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_provenance.
- NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_assertion wasGeneratedBy ECO_0000203 NP438001.RAS7zhXKN-tHuq1I0dYK8HKPa5kgE4YW2hB3D08xd-6Wc130_provenance.